CSF1R and Alzheimer disease: In a recent study, in order to investigate the role of microglia in the early phases of AD plaque formation, the researchers designed and synthesized a unique brain-penetrant CSF1R inhibitor (PLX5622) allowing for the sustained and specific elimination of microglia prior to and during the period of plaque formation in the 5xFAD mice.